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Introduction: High dose therapy with autologous stem cell transplantation (HD-ASCT) is 
associated with increased risk of late effects. Our aim was to assess lifestyle behavior and 
factors associated with unhealthy lifestyle among HD-ASCT-treated lymphoma survivors 
(HD-ASCT-LS). 
Material and methods: We conducted a national cross-sectional study of HD-ASCT-LS 
treated during 1987-2008. Among 399 eligible participants, 312 (78%) completed patient-
reported outcomes measures (PROMs) on lifestyle behavior (physical activity, overweight, 
smoking and alcohol consumption), chronic fatigue (CF) and somatic and mental illness. We 
assessed lifestyle according to WHO recommendations. Multivariable logistic regression 
models were used to study associations between variables. A comparison to the general 
population was performed. 
Results: Mean age at survey was 54.6 years, 60% were men, 55% sedentary, 55% 
overweight, 18% smokers and 5% had unhealthy alcohol consumption. Being sedentary was 
positively associated with older age, low household income, CF and higher somatic burden 
(≥4 self-reported somatic conditions). Overweight was positively associated with male gender 
and negatively associated with increased number of chemotherapy regimens prior to HD-
ASCT. Current smoking was positively associated with living alone and CF, and negatively 
associated with older age. Male gender, CF and higher somatic burden increased the risk of an 
unhealthier lifestyle whereas increased number of chemotherapy regimens prior to HD-ASCT 
decreased the risk. 
HD-ASCT-LS were significantly less sedentary, less overweight, and had a lower likelihood 
of smoking than the controls. 
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Discussion: Assessed by PROMs, unhealthy habits was frequent among HD-ASCT-LS and 
associated with comorbidity. Nevertheless, compared with controls significantly more HD-
ASCT-LS met lifestyle recommendations. These results indicate that the HD-ASCT-LS may 
consist of two groups, the adhering group with less comorbidity and the non-adhering group 
with more comorbidity. Our findings illustrate the necessity of recommendations and support 




Lymphoma affects mostly elderly patients, but some types are also predominant in younger 
age groups. There is an increasing number of long-term lymphoma survivors (LS), due to 
increased incidence and treatment improvements [1]. For the majority of lymphoma subtypes, 
patients in complete remission 2-3 years after standard therapy, have a long-term survival of 
80-90% or more compared with the normal population [2].  
It is well documented that lymphoma therapy is associated with an increased risk of 
late effects such as fatigue, cardiovascular disease, secondary malignancies and reduced 
health-related quality of life (HRQoL) [3,4,5]. A healthy lifestyle may positively influence the 
presence and outcome of these late effects, especially cardiovascular disease [6]. Among 
cancer patients and survivors, a healthy lifestyle may in addition decrease fatigue, improve 
physical functioning and increase HRQoL [7, 8].  
There are reports of a positive association between lifestyle behavior, especially 
physical activity (PA), on HRQoL in both non-Hodgkin (NHL) and Hodgkin lymphoma (HL) 
survivors [9, 10]. Presumably, a healthy lifestyle might have an even greater impact on health 
status for lymphoma survivors after high-dose chemotherapy with autologous hematopoietic 
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stem-cell transplantation (HD-ASCT), as the highly intensive treatment seems to be 
associated with a high risk of late effects [11]. 
Lifestyle recommendations for the general population are well established, and apply 
equally for cancer survivors [12]. Nevertheless, a large cross-sectional study on 9105 cancer 
survivors treated for different types of solid cancers reported 30-47% to be physically active, 
83-92% were non-smokers and only 15-19% had a healthy diet containing fruit and 
vegetables (5-a-day) [7]. Adherence to all three recommendations assessed together (PA, non-
smoking and 5-a-day) was only 5%. Results for NHL survivors are similar [9, 10]. In 
addition, female gender, lower perceived health competence and comorbid limitations were 
associated with a sedentary lifestyle [9].  
This study is part of a cross-sectional national multicenter study assessing a wide 
range of late effects in an unselected population of HD-ASC- treated lymphoma survivors 
(HD-ASCT-LS) [13, 14]. The main purpose of the present study was to acquire information 
regarding lifestyle behavior in this group of survivors, which, to our knowledge, has not been 
studied previously. Our second purpose was to evaluate associations between adherence to 
lifestyle recommendations and 1) patient and treatment characteristics, and 2) somatic or 
mental comorbidity with special emphasis on chronic fatigue (CF).  
We hypothesized that 1) HD-ASCT-LS are more likely to adhere to recommended 
lifestyle behavior than the general population and 2) that an unhealthy lifestyle is associated 
with a higher degree of comorbidity and / or CF in this group of survivors.  
 
Patients and methods 
Study population 
All lymphoma survivors aged ≥18 years treated with HD-ASCT in Norway over two decades 
(1987-2008) were eligible.  Identification of study participants was based on reports from 
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multidisciplinary meetings were HD-ASCT patients routinely were discussed and Oslo 
Lymphoma Registry (Oslo University Hospital), and registries dedicated for HD-ASCT 
treated patients only (the other University hospitals). Active cancer treatment was an 
exclusion criterion. Overall, 399 eligible survivors were invited by mail, 312 (78%) 
completed questionnaires and 274 (69%) attended an extensive clinical examination in the 
period 2012-2014 (Figure 1) [13, 14].  
Lymphoma characteristics and treatment 
Information regarding lymphoma characteristics and treatment details were retrieved 
retrospectively from medical records or the lymphoma registry at Oslo University Hospital.  
Treatment was given according to international guidelines, and with a consensus in the 
Norwegian lymphoma group. During 1987-1996, patients received total body irradiation and 
high-dose cyclophosphamide as myeloablative treatment, while BEAM (carmustine, 
etoposide, cytarabine and melphalan) was applied after 1996 (15). Survivors were categorized 
according to lymphoma entity before HD-ASCT (HL, indolent NHL (iNHL) and aggressive 
NHL (aNHL)), number of regimens prior to HD-ASCT (one, two or ≥three), whether they had 
received radiotherapy or not and if they had recurrent disease after HD-ASCT or not.  
  
Patient reported outcome measures  
The participants completed a set of well-established patient reported outcome measures 
(PROMs) assessing PA, smoking, alcohol consumption and dietary habits [16], Type D 
personality (Type D Scale-14 (DS14)) [17], CF (Fatigue Questionnaire (FQ)) [18], post-
traumatic stress disorder (PTSD) (The Impact of Event Scale (IES)) [19], anxiety and 
depression (Hospital Anxiety and Depression Score (HADS)) [20]. In addition, they reported 
on prior or present somatic illness (secondary malignancy, heart-, lung-, kidney-, liver-, 
thyroidal- or hematological disease, stroke, high blood pressure, diabetes mellitus, gastric 
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ulcer, arthritis, osteoarthritis, back pain or other diseases). In case of somatic illness, they 
were asked whether this affected activity of daily living (ADL) or not. 
 
Socio-demographic characteristics  
Socio-demographic information was obtained from questionnaires. Household income was 
dichotomized into groups with more or less than 600.000 NOK/year (≈€ 63.900). Education 
was dichotomized into ≤12 years of education or more. Being in a paired relationship was 
defined as being either married or cohabitant. 
 
Lifestyle behavior recommendations 
The lifestyle recommendations are according to Norwegian guidelines [12] and include: 1) 
Moderate PA for ≥150 min per week or strenuous PA for ≥75 min per week, 2) a normal 
weight defined as body mass index (BMI) <25, 3) non-smoking, 4) an alcohol consumption 
less than 10g/day and 20g/day for women and men respectively and 5) a healthy diet. Due to 
the complexity of diet recommendations we decided to investigate adherence to 5-a-day [12].  
 
Main outcomes 
Participants reported PA in frequency, intensity and duration. Multiplying frequency and 
duration gave minutes (minimum-maximum) of physical activity/week. A time range that 
included recommended time with PA was defined as adherence. PA was dichotomized into 
physically active or sedentary according to whether the PA recommendation was met or not. 
Information on height and weight was based on clinical examination when this was available 
(n=271) and self-report for the remaining subjects (n=41). BMI was calculated as kg/m2 and 
categorized into BMI<25 (normal weight) or BMI ≥25 (overweight). Smoking was 
dichotomized into yes (current or occasionally) or no (never or prior). An unhealthy alcohol 
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consumption was defined by ≥6 units/week and ≥12 units/week for women and men, 
respectively. One alcohol unit was defined as 12g. Healthy diet was dichotomized into yes or 
no, with regard to eating 5-a-day or not.  
 In order to grade the unhealthy lifestyle, we analysed the total number of guidelines 
not met (PA, BMI <25, non-smoking and alcohol consumption), as a summary score. This 
provided every participant with a score from 0-4, with four representing the most unhealthy 
lifestyle according to guidelines. 
 
A respectively high and low number of participants were not adhering to diet (n=305) and 
alcohol (n=15) recommendations. Hence, we deliberately omitted separate analyses on these 
issues. We included the habit of alcohol consumption in the summary score on unhealthy 
lifestyle, and used BMI as a surrogate variable for energy balance. 
 
Comorbidity characteristics 
Operationalization of PROMs (Type D personality, CF and HADS) have been described 
earlier [14]. Internal consistency (Cronbach`s alpha) in our study was; type D personality, 
0.90 for negative affectivity and 0.44 for social inhibition; CF, 0.92, 0.93 and 0.80 for total, 
physical and mental fatigue and HADS, 0.82 for depression and 0.86 for anxiety.  
Assessment for PTSD was performed using IES, which combines seven questions on 
intrusion and eight questions on avoidance to produce a sum score (0-77). We considered a 
cut-off ≥35 to be consistent with a probability of PTSD. Internal consistency was 0.92 for 
intrusion and 0.90 for avoidance.  
In order to grade mental burden, we constructed a summary score (0-3) based on 
presence of depression, anxiety and/or PTSD. Survivors were dichotomized according to 
scores 0-1 or 2-3 (high mental burden). We chose not to include CF in this summary score, as 
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we aimed to explore CF as an independent risk factor for not adhering to lifestyle 
recommendations. In addition, we chose not to include cognitive difficulties (memory and 
concentration problems) to avoid interaction with CF because of highly overlapping 
questions. 
Based on self-report of somatic disease we constructed a summary score for the 
burden of somatic disease, and chose to dichotomize between 0-3 and ≥4 somatic conditions 
(high somatic burden), modified after a previous report [21]. We elaborated on consequences 
of somatic disease by dichotomizing into groups based on whether the somatic disease 
interfered on ADL or not.  
 
Control group 
We performed a comparison between our study group and the general population represented 
by age- and gender matched persons (1:5 matching) from the sixth survey of the Tromsø 
study (Tromsø 6) [22]. Tromsø 6 is a population-based study conducted during 2007-2008, 
consisting of questionnaires and clinical investigations. The Tromsø study population is 
considered representative of the Norwegian population [23]. PROMs regarding PA and 
smoking were identical to our study, whereas the wording of questions regarding alcohol 




We used descriptive statistics to study population characteristics. The agreement between 
measured and self-reported BMI was calculated using kappa. To assess associations between 
variables predictive of a certain outcome, (non-adherence to guidelines) we performed age 
adjusted and multivariable analyses using binary and ordinal logistic regression. Ordinal 
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regression was used to assess the association between an increasing number of unhealthy 
lifestyle factors (later referred to as a more unhealthy lifestyle) and possible risk factors. 
Variables with a p-value ≤ 0.25 in age adjusted models were included as candidates in a 
multivariable model using a backward selection process. Level of education and income were 
included as covariates in the multivariable models, to adjust for socio-economical status. 
Associations are reported as odds ratios (OR) with 95% confidence intervals ([95% CI]). A p-
value ≤ 0.05 (two-sided) was considered statistically significant. SPSS version 24 was used as 
statistical software (IBM Corporation, New York, USA).  
 
Ethics 
The study was conducted according to the 1964 Helsinki declaration with amendments, and 
was approved by the Regional Ethics Committee. All participants gave a written informed 




There were no significant differences between respondents and non-respondents with regard 
to gender, lymphoma entity, myeloablative regimen, radiotherapy or age at diagnosis and HD-
ASCT. There was a significant difference in mean age at survey, 55.0 vs. 51.6 years for 
respondents and non-respondents, respectively (p-value=0.02). There was a good agreement 
between measured and self-reported BMI, kappa 0.80. 
The characteristics of the 312 participants are presented in Table 1. Median age at 
survey was 56 years (range 24-77) and median time from HD-ASCT to survey was 8.5 years 
(range 3.2-24.9). We found a high burden of comorbidity among the survivors as 31.1% had 




Lifestyle variables compared to controls 
Among the HD-ASCT-LS, 54.8% were sedentary, 55.1% had a BMI ≥25 (61% among men 
and 46% among women) and 17.9% were smoking (23.8%, 21.5% and 7.3% among survivors 
18-39, 40-64 and ≥65 years, respectively). Eating less than 5-a-day was reported by 98%, 
whereas only 4.8% had an alcohol consumption that exceeded recommendations (Table 1).  
Among the controls from the Tromsø 6 study, 59% were sedentary, 67% were 
overweight, (73% among men and 58% among women) and 28% were smoking. Stratified 
into age groups 18-39 years, 40-64 years and ≥65 years, the prevalence of smoking in Tromsø 
6 was 31%, 30% and 15.7%, respectively. Unhealthy alcohol consumption was found among 
3.7%, whereas 74% reported an intake of less than 5-a-day.  
Compared to the controls, the HD-ASCT-LS were significantly less sedentary (OR 0.77 
[0.60-0.99]), less overweight (OR 0.61 [0.48-0.78]) and the likelihood of smoking was lower 
(OR 0.55 [0.41-0.75]) (Table 1). 
 
Factors associated with each lifestyle behaviour 
The proportions of survivors being sedentary, overweight or smoking according to different 
characteristics is presented in Figure 2. The proportions of sedentary survivors were highest 
among those with type D personality, CF, or a high mental or somatic burden. Those treated 
with ≥3 regimens prior to HD-ASCT had the lowest frequency of overweight individuals.   
Physical activity: 
Being sedentary was significantly associated with a low household income (OR 2.12 [1.33-
3.39]), Type D personality (OR 2.20 [1.21-4.00]), CF (OR 2.86 [1.69-4.83]), high mental 
burden (OR 2.97 [1.29-6.86]) and high somatic burden (OR 2.86 [1.51-5.45]) in age adjusted 
models (Table 2). In the multivariable model, older age at survey (OR 1.23 [1.00-1.51]), low 
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household income (OR 1.97 [1.18-3.29]), CF (OR of 2.30 [1.31-4.04]) and somatic burden ≥4 
(OR 2.39 [1.21-4.74]) was significantly associated with a sedentary lifestyle. 
Overweight: 
In age adjusted models, higher age at survey (OR 1.21 [1.01-1.46], for every 10 years increase 
of age) and male gender (OR 1.78 [1.12-2.82]) were positively associated with increased risk 
of overweight, as opposed to a diagnosis of iNHL (OR 0.41 [0.19-0.90]) and treatment with 
≥3 regimens prior to HD-ASCT (OR 0.31 [0.15-0.67]). In the multivariable model, men had 
an increased risk of being overweight in comparison to women (OR 2.03 [1.24-3.31]). 
Survivors with ≥3 regimens prior to HD-ASCT had a 70% decreased risk of being overweight 
compared with those with fewer regimens (OR 0.31 [0.14-0.67]). 
Smoking: 
Smoking daily or occasionally was significantly related to age at survey (OR 0.72 [0.57-0.91], 
per 10 years increase) and with not being in a paired relationship (OR 2.12 [1.12-3.94]) in age 
adjusted models. In the multivariable model every 10 years increase of age reduced the risk of 
smoking by 30% (OR 0.70 [0.54-0.90]), whereas not being in a paired relationship (OR 2.38 
[1.15-4.94]) and CF (OR 2.12 [1.10-4.06]) increased the risk of smoking. 
 
A more unhealthy lifestyle 
Figure 3a shows the distribution of survivors adhering to 0-4 lifestyle factors. The majority 
met 3-4 recommendations (57%). Figure 3b illustrates the proportion of HD-ASCT-LS not 
adhering to each lifestyle factor according to total number of recommendations not met. A 
sedentary lifestyle and overweight are frequent at all levels of non-adherence. Smoking and 
unhealthy alcohol consumption is more frequent together with another unhealthy factor, than 




Factors associated with a more unhealthy lifestyle 
In age adjusted models, there was a significant association between a more unhealthy lifestyle 
and male gender (OR 1.57 [1.02-2.41]) (Table 3). Survivors with a diagnosis of iNHL (vs. 
aNHL) and those with ≥3 regimens prior to HD-ASCT (vs. <3 regimens) were likely to have a 
more healthy lifestyle than compared groups (OR 0.44 [0.21-0.92] and OR 0.38 [0.19-0.75], 
respectively).  Survivors with Type D personality, CF or high somatic burden were more 
likely to have a more unhealthy lifestyle (OR 1.91 [1.12-3.25]), OR 2.41 [1.52-3.83] and OR 
2.50 [1.44-4.36], respectively).  
In the multivariable adjusted model, male survivors had increased risk of a more 
unhealthy lifestyle (OR 1.79 [1.13-2.84]) while survivors with ≥3 regimes prior to HD-ASCT 
had lower risk (OR 0.28 [0.14-0.59]). The highest risk of unhealthier lifestyle was seen 
among survivors with CF and those with ≥4 somatic diseases (OR 2.37 [1.44-3.88] and OR 
2.62 [1.45-4.75], respectively). 
 
Discussion 
We report on lifestyle among an unselected group of adult lymphoma survivors treated with 
HD-ASCT nation-wide over two decades. The majority had a sedentary lifestyle and were 
overweight. Disappointingly, one quarter of younger survivors were smoking. Overall, 
increased comorbidity was associated with a more unhealthy lifestyle, consistent with results 
from a study on NHL survivors in general [10]. Since cancer survivors are at risk of several 
late effects, it is worrisome that unhealthy habits are present at this frequency. To the best of 
our knowledge, the existing literature on prevalence of lifestyle behavior in lymphoma 
survivors are limited and studies of factors associated with lifestyle behavior among HD-
ASCT-LS are lacking. 
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Although the prevalence of unhealthy behavior is high, the HD-ASCT-LS were 
significantly less sedentary, less overweight and fewer were smoking compared with Tromsø 
6 controls. Adjusting for comorbidity in the statistical models would presumably have 
increased the difference even further, as comorbidity is more frequent among HD-ASCT 
survivors than the normal population [24] and associated with a more unhealthy lifestyle. 
Unfortunately, this adjustment was not possible due to differences in reporting of 
comorbidity. Our finding of a healthier lifestyle among HD-ASCT-LS than controls are in 
contrast to a report on American cancer survivors in general, where these cancer survivors 
were less physically active and more overweight than persons without a cancer history [25]. 
In line with our finding, smoking was less frequent among cancer survivors than the general 
population [25].  
A possible explanation for these differences could lie in the concept of teachable 
moments, which implies that a cancer diagnosis can be a driving force in adoption of health-
promoting behavior [26]. Perhaps this effect is even stronger if one experiences relapse of 
cancer, as was the case for the majority of our study group. Selection by survival might be 
another explanation for the healthier lifestyle in our study group compared with the controls. 
One could argue that our study population is a highly selected portion of all lymphoma 
patients receiving HD-ASCT, because they are still alive and they might always have had a 
healthy lifestyle. In a recent publication better prognosis was reported among patients with 
aggressive lymphoma who were physically active, and among patients with indolent 
lymphoma obesity was associated with a worse prognosis [27], which supports this theory.  
 
About half of the participants in our study reported to have a sedentary lifestyle, which is a 
lower proportion than reported among cancer survivors in general (70%) [28], whereas studies 
among non-HD-ASCT treated lymphoma survivors in particular report higher or similar 
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proportions (75% and 52%, respectively) [9, 10]. The difference in results between Bellizzi´s 
study [9] and our, could be explained by a slightly less stringent definition of being sedentary, 
in addition to younger age and higher level of education among participants in our study. 
NHL survivors in Bellizzi’s report were 3.7 times more likely to be physical inactive if they 
reported greater comorbid limitations [9]. This is comparable to our finding of a relationship 
between CF, burden of somatic comorbidity and a sedentary lifestyle.  
 
Overweight or obesity are identified as late effects among cancer survivors [23, 25, 29]. 
However, the HD-ASCT-LS were less overweight than the controls, and less overweight than 
both NHL survivors (64%) and cancer survivors in general (66%) [10, 25]. A possible 
explanation might be that higher cumulative chemotherapy doses lead to physiological 
changes which results in decreased weight. A higher number of regimens was associated with 
a lower likelihood of overweight, and gives empirical support to this theory. Nonetheless, the 
55% of overweight HD-ASCT-LS would presumably achieve health-benefits in case of 
weight reduction [6].  
Based on our data it was not possible to explore whether the transplantation itself 
made a person more likely to live a healthy life, or whether the positive shift in lifestyle was a 
result of living with lymphoma and requiring chemotherapy treatment repeatedly. However, 
compared to previous studies on NHL survivors in general [9, 10] HD-ASCT-LS seems to 
have a lower prevalence of sedentary lifestyle and overweight. Hence, the transplantation 
experience might be influential on adherence to lifestyle recommendations. 
 
The prevalence of smoking has been reported to be higher among younger than older cancer 
survivors [28], and a low prevalence of smoking has also been reported among older NHL 
survivors (6%) [10]. A similar pattern regarding smoking status was found among the HD-
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ASCT-LS. Hence, it is highly relevant to increase focus on smoking cessation among younger 
HD-ASCT-LS. 
 
Existing literature on long-term lymphoma survivors and diet is scarce. Two studies report 
44-66% adherence to diet recommendations [10, 30] which is remarkably higher than the 
2.2% eating 5-a-day in our study. At surveys people tend to present a favorable image of 
themselves, and the finding of only 5% reporting an unhealthy alcohol consumption might be 
underestimated due to this social desirability bias in self-reports [31]. Unfortunately, a 
comparison with Tromsø 6 controls could not be done due to differences in PROMs. These 
two latter aspects illustrate the difficulties with internal and external validity in assessing and 
comparing drinking and dietary habits. Still, the findings give a strong implication for 
integrating nutritional advice into follow-up as part of advice on a healthy energy balance.  
 
An increased risk of an unhealthier lifestyle was found among men, corroborating previous 
reports showing that male cancer survivors are less likely to adopt health-promoting behaviors 
[10, 26]. CF and a high somatic burden were independent predictors of a more unhealthy 
lifestyle, and together with the higher adherence among HD-ASCT-LS vs. controls to lifestyle 
recommendations, this indicate that the HD-ASCT-LS may consist of two groups. The 
adhering, not fatigued group with less somatic comorbidity in contrast to the group who do 
not adhere to guidelines, experience CF and/or have a high somatic burden. As PA may 
reduce CF, it is important to recognize these survivors and initiate support to improve level of 
PA. 
 
About 20% of HD-ASCT-LS had a high somatic burden. Even though we report past and 
present comorbidity, this seems remarkably higher than the 2.5% incidence of ≥3 late-effects 
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previously reported [32]. Another report on health problems after hematopoietic stem cell 
transplantation (HSCT) found on average 3.5 medical problems after HD-ASCT or 
allogeneic-HSCT [24]. The numbers are not directly comparable due to differences in 
methodology and study population. Nonetheless, HD-ASCT-LS are at risk of many late 
effects [32] and more health problems than the normal population [24], which our findings 
support.  
 
The major strength of our study is the completeness of the study population. Due to the 
Norwegian public health system, personal identification number and national collaboration, 
all eligible HD-ASCT-LS were invited to participate. A high number of survivors returned the 
questionnaire (78%), assuring representativeness. In order to compare lifestyle behavior with 
the normal population we matched survivors with subjects from Tromsø 6 study, which is 
considered to be representative for the general population [22-23].  
Outcome data in our study were based on PROMs, which are associated with recall 
bias and represents a weakness in our study. However, we believe this bias was similar to 
subjects from the Tromsø 6 study because identical PROMs were used. Self-reported BMI 
was used for a minority of HD-ASCT-LS (13%), which might have introduced a bias due to 
differences in self-reported and measured BMI. Nevertheless, we believe the potential bias is 
minor based on good agreement between the two methods and a sensitivity analysis that did 
not alter the main results. 
Our study is unable to address causality, because of the cross-sectional design. 
Nevertheless, we assume somatic illness and health-related behavior affects each other 




In conclusion, HD-ASCT-LS have a high risk of late effects and the high prevalence of a 
somatic burden reported herein is more pronounced than reported earlier. Our results raise the 
attention to HD-ASCT-LS with CF and high somatic burden, and illustrate the necessity of 
incorporating recommendations and support for improving health-related behavior into cancer 
survivorship plans. The patient-doctor meeting is a great opportunity to increase awareness, 
provide knowledge, initiate support for lifestyle changes and thereby empower survivors in 
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Figure legends 
Figure 1 Flowchart of study population. 
 
Figure 2 Proportion of lymphoma survivors after high dose therapy with autologous 
hematopoietic stem cell transplantation not adhering to lifestyle recommendations, by 
different characteristics of the study-population. Abbreviations: HD-ASCT, high dose 
chemotherapy with autologous hematopoietic stem cell transplantation; iNHL, indolent non-
Hodgkin lymphoma; aNHL, aggressive non-Hodgkin lymphoma; HL, Hodgkin lymphoma. 
 
Figure 3a Proportion of lymphoma survivors after high dose therapy with autologous 
hematopoietic stem cell transplantation adhering to a number of lifestyle recommendations 
(physical activity: ≥150 min/week of moderate physical activity or ≥75 min/week of 
strenuous activity, body mass index <25, non-smoking and alcohol consumption ≤6 or ≤12 
alcohol units per week for women and men, respectively). 
 
Figure 3b Proportion of lymphoma survivors after high dose therapy with autologous 
hematopoietic stem cell transplantation not adhering to each lifestyle recommendation, 
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according to total number of recommendations not met (sedentary: <150 min/week of 
moderate physical activity or <75 min/week of strenuous physical activity, body mass index 
≥25, smoking, alcohol consumption >6 or >12 alcohol units per week for women and men, 
respectively). 
 
Table 1. Characteristics of study population at survey and age- and gender matched 
controls from the Tromsø 6 study 
 HD-ASCT lymphoma 
survivors 
N=312 
Tromsø 6 study 
controls 
N=1560 
SOCIODEMOGRAPHICS:   
Age at diagnosis, median (range) 42 (10-65)  
Age at HD-ASCT,  median (range) 46 (18-67)  
Age at survey, median (range) 56 (24-77)  56 (30-79) 
Time HD-ASCT - survey in years, median (range) 8.5 (3.2-24.9)  
Gender:   
Female, n (%) 125 (40) 625 (40) 
Male, n (%) 187 (60) 935 (60) 
In a relationshipi, n (%) 227 (73) 966 (62) 
Education >12 years, n (%) 141 (45) 618 (40) 
Household income highii, n (%) 133 (43) 707 (45) 
LYMPHOMA AND TREATMENT:   
Lymphoma entity:   
Aggressive Non-Hodgkin lymphomaiii, n (%) 209 (67) - 
Indolent Non-Hodgkin lymphomaiv, n (%) 31 (9.9) - 
Hodgkin lymphoma, n (%) 72 (23) - 
Stage III-IV at diagnosis, n (%) 214 (69) - 
Treatment regimes prior to HD-ASCT:   
    1, n (%) 92 (29) - 
    2, n (%) 176 (56) - 
  ≥3, n (%) 44 (14) - 
Radiotherapyv, n (%) 201 (64) - 
Relapse after HD-ASCT, n (%) 70 (22) - 
COMORBIDITY:   
Type D personality, n (%) 64 (21) - 
Chronic fatigue, n (%) 97 (31) - 
Mental burden ≥2, n (%) 34 (11) - 
Somatic burden ≥4, n (%) 58 (19) - 
Somatic illness with interference on ADL, n (%) 121 (39) - 
LIFESTYLE VARIABLES:   
Sedentaryvi, n (%) 171 (55) 918 (59) 
Body mass index ≥25, n (%) 172 (55) 1042 (67) 
Smokingvii, n (%) 56 (18) 437 (28) 
Unhealthy alcohol consumptionviii *, n (%) 15 (4.8)  57 (3.7) 
Diet less than 5-a-dayix *, n (%) 305 (98) 1146 (74) 
Abbreviations: HD-ASCT, high dose chemotherapy with autologous hematopoietic stem cell transplantation; 
ADL, activity of daily living. 
*Patient-reported outcome measures were different in our study and Tromsø 6. Direct comparison between 
groups was not applicable. 
Missing values, study group: In a relationship, n=1; education, n=2; income, n=9; stage at diagnosis, n=1; Type 
D personality, n=26; chronic fatigue, n=1; somatic burden ≥4, n=12; mental burden ≥2, n=2; somatic illness with 
interference on ADL, n=72; sedentary, n=5; smoking, n=2; unhealthy alcohol consumption, n=4.   
Missing values, control group: Education, n=17; income, n=90; sedentary, n=68; body mass index, n=1; 
smoking, n=29; unhealthy alcohol consumption, n=20; diet less than 5-a-day, n=93.   
i Married or cohabitant. 
ii High/Low income: >/ ≤600.000 nkr/year ≈€ 62.900 (study population) and >/ ≤551.000 nkr/year ≈€ 57700 
(Tromsø 6). 
iii Includes: Lymphoblastic lymphoma, n=21; Burkitt lymphoma, n=11; diffuse large B-cell lymphoma, n=69; 
mantle cell lymphoma, n=41; T-cell lymphomas, n=32; transformed lymphoma, n=33. 
iv Includes follicular or other indolent lymphomas. 
v Radiotherapy part of treatment, prior to HD-ASCT or as consolidation to such. 
vi <150 min/week of moderate physical activity or <75 min/week of strenuous physical activity. 
vii Smoking current or occasionally. 
viii Alcohol consumption >6 or >12 alcohol units per week for women and men, respectively. 
ix Three vegetables and two fruits per day.  
                                                            
 
Table 2. Odds ratios for non-adherence to lifestyle factors in age adjusted and multivariable adjusted models* 
 Sedentaryi Body mass index ≥25 Smoking 
 Age adjusted model Multivariable model* Age adjusted model Multivariable model* Age adjusted model Multivariable model* 
 OR 95% CI p-value OR 95% CI p-value OR 95% CI p-
value 
OR 95% CI p-
value 
OR 95% CI p-
value 
OR 95% CI p-value 
SOCIO-                   
DEMOGRAPHICS:                   
Age at survey,   1.14 0.95-1.38 0.1 1.23 1.00-1.51 0.05 1.21 1.01-1.46 0.04 1.21 0.99-1.48 0.06 0.72 0.57-0.91 0.006 0.70 0.54-0.90 0.006 
10 years                   
Gender:                   
Female 1 Ref.  1 Ref.  1 Ref.  1 Ref.  1 Ref.  1 Ref.  
Male 1.15 0.73-1.82 0.56 1.21 0.73-2.00 0.47 1.78 1.12-2.82 0.02 2.03 1.24-3.31 0.005 1.12 0.61-2.03 0.74 1.28 0.67-2.46 0.46 
In a relationshipii:                   
Yes 1 Ref.     1 Ref.     1 Ref.  1 Ref.  
No 1.24 0.74-2.09 0.41    0.73 0.44-1.21 0.22    2.12 1.14-3.94 0.02 2.38 1.15-4.94 0.02 
Education:                   
>12 years 1 Ref.  1 Ref.  1 Ref.  1 Ref.  1 Ref.  1 Ref.  
≤12 years 1.10 0.70-1.74 0.67 0.96 0.57-1.61 0.87 0.98 0.62-1.55 0.93 0.89 0.54-1.47 0.66 1.84 0.98-3.42 0.06 1.80 0.93-3.48 0.08 
Household incomeiii :                   
>600.000 nkr 1 Ref.  1 Ref.  1 Ref.  1 Ref.  1 Ref.  1 Ref.  
≤600.000 nkr 2.12 1.33-3.39 0.002 1.97 1.18-3.29 0.01 1.00 0.63-1.59 0.99 1.05 0.64-1.73 0.84 1.35 0.74-2.47 0.33 0.82 0.40-1.70 0.59 
LYMPHOMA AND                   
TREATMENT:                   
Lymphoma entity:                    
aNHLiv 1 Ref.     1 Ref.     1 Ref.     
iNHLv 0.97 0.54-1.75 0.91    0.41 0.19-0.90 0.03    1.39 0.52-3.70 0.51    
HL 0.59 0.28-1.27 0.18    0.94 0.52-1.70 0.85    0.75 0.35-1.59 0.46    
Number of regimes                   
prior to HD-ASCT:                   
1 regimen 1 Ref.     1 Ref.  1 Ref.  1 Ref.     
2 regimes 1.02 0.61-1.72 0.94    1.01 .60-1.70 0.97 1.10 0.64-1.90 0.72 0.62 0.33-1.20 0.16    
≥3 regimens 0.64 0.31-1.32 0.23    0.31 0.15-0.67 0.003 0.30 0.14-0.67 0.003 0.69 0.26-1.79 0.44    
Radiotherapyvi:                   
No 1 Ref.     1 Ref.     1 Ref.     
Yes 1.22 0.75-1.98 0.42    0.69 0.43-1.12 0.14    0.76 0.41-1.41 0.38    
COMORBIDITY:                   
Type D  personalityvii:                   
No 1 Ref.     1 Ref.     1 Ref.     
Yes 2.20 1.21-4.00 0.01    1.21 0.68-2.13 0.52    1.29 0.65-2.58 0.47    
Chronic fatigue:                   
No 1 Ref.  1 Ref.  1 Ref.     1 Ref.  1 Ref.  
Yes 2.86 1.69-4.83 <0.001 2.30 1.31-4.04 0.004 1.28 0.78-2.01 0.33    1.61 0.88-2.95 0.12 2.12 1.10-4.06 0.02 
Mental burden ≥2viii:                   
No 1 Ref.     1 Ref.     1 Ref.     
Yes 2.97 1.29-6.86 0.01    0.72 0.35-1.49 0.38    1.65 0.71-3.79 0.24    
Somatic burden ≥4ix:                   
No 1 Ref.  1 Ref.  1 Ref.     1 Ref.     
Yes 2.86 1.51-5.45 0.001 2.39 1.21-4.74 0.01 1.34 0.74-2.42 0.33    1.66 0.81-3.43 0.17    
Somatic illness with                    
interference on ADL:                   
No 1 Ref.     1 Ref.     1 Ref.     
Yes 1.63 0.96-2.74 0.07    0.93 0.56-1.55 0.78    1.12 0.57-2.22 0.74    
Bold type indicates statistical significance, p-value <0.05. 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; Ref., reference; iNHL, indolent non-Hodgkin lymphoma; aNHL, aggressive non-Hodgkin lymphoma; HL, Hodgkin 
lymphoma; HD-ACST, high dose chemotherapy with autologous hematopoietic stem cell transplantation; ADL, activity of daily living. 
*Multivariable model from a backward selection process additionally adjusted for age at survey, gender, education and household income. 
i <150 min/week of moderate physical activity or <75 min/week of strenuous physical activity. 
ii Married or cohabitant. 
iii 600.000 nkr/year ≈€ 62.900/year. 
iv Includes: Lymphoblastic lymphoma, n=21; Burkitt lymphoma, n=11; diffuse large B-cell lymphoma, n=69; mantle cell lymphoma, n=41; T-cell lymphomas, n=32; 
transformed lymphoma, n=33. 
v Includes follicular or other indolent lymphomas. 
vi Radiotherapy part of treatment, prior to HD-ASCT or as consolidation to such. 
vii Type D personality; negative affectivity and social inhibition. 
viii Presence of post traumatic stress syndrome, depression caseness and/or anxiety caseness 
ix Based on self report of secondary malignancy, heart disease (heart failure, myocardial infarction, angina pectoris), hypertension, stroke, asthma, COPD, diabetes mellitus, 
gastric ulcer, anemia, blood-, thyroid-, liver or kidney disease, arthritis, osteoarthritis, back pain or other disease. 
                                                            
Table 3. Odds ratios for a more unhealthy lifestylei in age adjusted and multivariable adjusted models*, 
assessed by ordinal logistic regression 
 Age adjusted model Multivariable model* 
 OR 95% CI p-value OR 95% CI p-value 
SOCIO- DEMOGRAPHICS:       
Age at survey, 10 years 1.09 0.92-1.30 0.29 1.13 0.94-1.35 0.20 
Gender:       
Female 1 Ref.  1 Ref.  
Male 1.57 1.02-2.41 0.04 1.79 1.13-2.84 0.01 
In a relationshipii:        
Yes 1 Ref.     
No 1.25 0.77-2.01 0.37    
Education:       
>12 years 1 Ref.  1 Ref.  
≤12 years 1.11 0.73-1.70 0.61 1.05 0.66-1.66 0.84 
Household incomeiii:       
>600.000 nkr 1 Ref.  1 Ref.  
≤600.000 nkr 1.48 0.97-2.28 0.07 1.44 0.91-2.28 0.12 
LYMPHOMA AND TREATMENT:       
Lymphoma entity:       
aNHLiv 1 Ref.     
iNHLv 0.44 0.21-0.92 0.03    
HL 0.78 0.45-1.34 0.36    
Number of regimes prior to HD-ASCT:       
1 regimen 1 Ref.  1 Ref.  
2 regimes 0.79 0.49-1.26 0.32 0.78 0.47-1.29 0.33 
≥3 regimens 0.38 0.19-0.75 0.006 0.28 0.14-0.59 0.001 
Radiotherapyvi:       
No 1 Ref.     
Yes 0.82 0.53-1.28 0.39    
COMORBIDITY:       
Type D  personalityvii:       
No 1 Ref.     
Yes 1.91 1.12-3.25 0.02    
Chronic fatigue:       
No 1 Ref.  1 Ref.  
Yes 2.41 1.52-3.83 <0.001 2.37 1.44-3.88 0.001 
Mental burden ≥2viii:       
No 1 Ref.     
Yes 1.64 0.83-3.23 0.15    
Somatic burden ≥4ix:       
No 1 Ref.  1 Ref.  
Yes 2.50 1.44-4.36 0.001 2.62 1.45-4.75 0.001 
Somatic illness with interference on ADL:       
No 1 Ref.     
Yes 1.21 0.74-1.98 0.44    
Bold type indicates statistical significance, p-value <0.05. 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; iNHL, indolent non-Hodgkin lymphoma; aNHL, 
aggressive non-Hodgkin lymphoma; HL, Hodgkin lymphoma; HD-ASCT, high dose chemotherapy with 
autologous hematopoietic stem cell transplantation; ADL, activity of daily living. 
* Multivariable model from a backward selection process additionally adjusted for age at questionnaire, gender, 
education and income. 
i Sedentary: <150 min/week of moderate physical activity or <75 min/week of strenuous physical activity, BMI 
≥25, smoking, alcohol consumption >6 or >12 alcohol units per week for women and men, respectively. 
ii Married or cohabitant. 
iii 600.000 nkr/year ≈€ 62.900/year. 
iv Includes: Lymphoblastic lymphoma, n=21; Burkitt lymphoma, n=11; diffuse large B-cell lymphoma, n=69; 
mantle cell lymphoma, n=41; T-cell lymphomas, n=32; transformed lymphoma, n=33.  
v Includes follicular or other indolent lymphomas. 
vi Radiotherapy part of treatment, prior to HD-ASCT or as consolidation to such. 
vii Type D personality; negative affectivity and social inhibition 
viii Presence of post traumatic stress syndrome, depression caseness and/or anxiety caseness 
ix Based on self report of secondary malignancy, heart disease (heart failure, myocardial infarction, angina 
pectoris), hypertension, stroke, asthma, COPD, diabetes mellitus, gastric ulcer, anemia, blood-, thyroid-, liver or 
kidney disease, arthritis, osteoarthritis, back pain or other disease. 
 










































Number of recommendations not met
Figure 3b
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